Related Experiment Videos
Beta-lactamase stability of imipenem
The Journal of Antimicrobial Chemotherapy
|December 1, 1986
Summary
Imipenem demonstrates stability against various beta-lactamase enzymes. Unlike other antibiotics, imipenem showed no detectable hydrolysis, indicating its effectiveness against resistant bacteria.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Beta-lactamase enzymes confer resistance to beta-lactam antibiotics.
- Understanding antibiotic-beta-lactamase interactions is crucial for combating antimicrobial resistance.
Purpose of the Study:
- To compare the stability and interactions of imipenem with various beta-lactamases against other beta-lactam antibiotics.
- To evaluate imipenem's resistance profile to different classes of beta-lactamase enzymes.
Main Methods:
- Analysis of imipenem's interaction with representative beta-lactamases (penicillinases, cephalosporinases, and novel beta-lactamases).
- Comparative study with cefazolin, cefuroxime, cefoxitin, cefotaxime, ceftazidime, mezlocillin, piperacillin, and penicillin G.
Main Results:
- Group A enzymes (penicillinases) hydrolyzed penicillins and early cephalosporins.
- Group B enzymes hydrolyzed newer cephalosporins and cephamycins but not imipenem.
- Group C enzymes hydrolyzed newer cephalosporins but not cephamycins or imipenem.
- Imipenem exhibited moderate affinity but no detectable hydrolysis by any tested beta-lactamase.
Conclusions:
- Imipenem demonstrates broad stability against a range of clinically significant beta-lactamases.
- Imipenem's resistance to hydrolysis suggests its potential utility against infections caused by beta-lactamase-producing bacteria.